CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point

CellPoint : Advancing Molecular Technology Metabolic Cancer Imaging and Therapeutic Targeting Through Nuclear Medicine - Cell Point

home

pipeline

EC Mechanism

quarterly reports





Click here for animation

ABOUT CELL>POINT

The cornerstone of Cell>Point is metabolic imaging and therapeutic targeting through nuclear medicine. The company is developing novel radiopharmaceutical imaging agents, radiotherapeutic agents and local regional radio/chemotherapeutic drug delivery systems for the dia ... more

OUR PIPELINE

RESEARCH & DEVELOPMENT

Our pipeline includes more than 15 molecular imaging and therapeutic agents in addition to local regional chemotherapy and radiotherapy using In Situ Hydrogel ... more



Windows Media High Bandwidth Low Bandwidth	Real Player High Bandwidth Low Bandwidth

Cell>Point establishes European subsidiary

Cell>Point technology featured on Fox National News (video)

Cell>Point featured on NBC 9 News, Denver (video)

Cell>Point to present at Wachovia

Diagnostic Imaging April 2007 Article

CellPoint has cancer detection in its sights

Dr. F. David Rollo joins Cell>Point as President

Cell>Point has entered into long-term commitments to financially sponsor and support continuing research and development at M. D. Ander ... more

� copyright 2001-2007|Cell>Point L.L.C | all rights reserved | maintained by Link2City.com

Terry Colip

Home | About Us | Management Team | Scientific Advisory Board | Corporate fact Sheet
EC Mechanism of Action | Video | R & D | Agents Pipeline | News | Articles | Patents | Corp Financials | Contact Us